tm logo
BASILEA
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 04 Nov 2019

Last Applicant/ Owned by

Grenzacherstrasse 487

Basel

CH

4058

Serial Number

86936140 filed on 10th Mar 2016

Registration Number

N/A

Correspondent Address

EVAN A. RAYNES

SYMBUS LAW GROUP, LLC

1775 K STREET, NW, SUITE 1150

WASHINGTON, DC 20006

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

BASILEA

Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Veterinary products and preparations, namely, for the treatment and prevention of infections caused by bacteria, and Pharmaceutical and veterinary products andRead More

Classification Information


Class [001]
Chemical Products


Chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions, the treatment of infections and diseases and in the research and development of pharmaceuticals in the treatment of dermatological conditions, the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use

Class [005]
Pharmaceutical Products


Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Veterinary products and preparations, namely, for the treatment and prevention of infections caused by bacteria, and Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of infections caused by fungi, viruses, and rheumatoid arthritis; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of oncology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of gastroenterology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of neurology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of gynecology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of urology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of cardiology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of endocrinology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of nephrology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of hematology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of allergy; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of immunology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of psychiatry; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of anesthesiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of rheumatology; diagnostic preparations for medical clinical purposes; clinical medical reagents; all of the aforesaid for prescription only

Class [042]
Computer & Software Services & Scientific Services


Research and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and preparations

Mark Details


Serial Number

No 86936140

Mark Type

No Service Mark

Attorney Docket Number

No 3005-0109

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.03.01 -

Ovals as carriers and single line borders

Description of Design Search

The mark consists of the word "BASILEA" in blue surrounded by an oval in blue, with the interior of the oval in white.

Legal History


Show more

Status DateAction Taken
04th Nov 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
04th Nov 2019ABANDONMENT - NO USE STATEMENT FILED
18th May 2019CORRECTED NOA E-MAILED
16th May 2019DIVISIONAL PROCESSING COMPLETE
06th May 2019DIVISIONAL REQUEST RECEIVED
06th May 2019TEAS REQUEST TO DIVIDE RECEIVED
06th Mar 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05th Mar 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
05th Mar 2019EXTENSION 5 GRANTED
27th Feb 2019TEAS EXTENSION RECEIVED